[1]刘崇斌,黄柳维,李彩珍,等.阻断Pannexin-1 可减轻肾脏组织炎症细胞浸润和缓解顺铂诱导的急性肾损伤[J].南方医科大学学报,2019,(05):508.[doi:10.12122/j.issn.1673-4254.2019.05.02]
点击复制

阻断Pannexin-1 可减轻肾脏组织炎症细胞浸润和缓解顺铂诱导的急性肾损伤()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2019年05期
页码:
508
栏目:
出版日期:
2019-05-15

文章信息/Info

Title:
Blocking pannexin-1 alleviates cisplatin-induced acute kidney injury in mice by reducing renal inflammatory cell infiltration
作者:
刘崇斌黄柳维李彩珍沈燕婷王骏
关键词:
急性肾损伤顺铂肾小管上皮细胞pannexin-1
Keywords:
acute kidney injury cisplatin renal tubular epithelial cells pannexin-1
DOI:
10.12122/j.issn.1673-4254.2019.05.02
摘要:
目的探讨阻断pannexin-1在顺铂致急性肾损伤中的作用。方法将26只6~8周龄雄性C57BL/6小鼠随机分为对照组、顺 铂模型组、顺铂+Carbenoxolone 处理组。顺铂模型组、顺铂+Carbenoxolone 处理组予顺铂20 mg/kg 腹腔注射1 次,顺铂+ Carbenoxolone处理组于顺铂处理前30 min、处理后24、48 h分别腹腔注射Carbenoxolone 20 mg/kg,所有组于顺铂处理72 h处 死小鼠,留取血浆及肾组织样品进行下一步检测。RT-qPCR及Western blot 检测肾组织内pannexin-1 的表达水平;检测血浆 BUN、Scr水平评估肾功能;PAS 染色评估肾组织病理学改变;免疫组化检测肾损伤分子1(KIM-1)表达水平及RT-qPCR检测肾 损伤分子1与中性粒细胞明胶酶相关脂质运载蛋白(NGAL)mRNA水平评估肾小管损伤情况;免疫荧光检测肾组织F4/80+巨噬 细胞及CD4+ T细胞浸润水平;RT-qPCR及Western blot检测肾组织pannexin-1的mRNA及蛋白表达水平;用终浓度50 μmol/L 顺铂刺激人近端小管上皮细胞株HK-2 细胞4、6、12、18、24 h 构建体外顺铂致急性肾损伤模型;RT-qPCR及Western blot 检测 HK-2细胞pannexin-1的表达水平。结果与对照组相比,顺铂模型组肾组织pannexin-1蛋白水平及mRNA水平表达上调(P< 0.005);体外实验结果显示,与对照组相比,顺铂模型组的pannexin-1蛋白水平及mRNA水平表达水平上调(P<0.005);与顺铂 模型组相比,体内应用pannexin-1抑制剂Carbenoxolone处理后,可减轻顺铂所致的肾脏损伤,肾小管损伤程度明显减轻,顺铂+ Carbenoxolone处理组的血浆BUN、Scr水平回降(P<0.01),肾组织KIM-1、NGAL表达减少(P<0.05),肾组织浸润的F4/80+巨噬 细胞(P<0.01)及CD4+ T 细胞(P<0.05)减少。结论在顺铂所致急性肾损伤小鼠模型中,Pannexin-1 表达显著上调,阻断 pannexin-1减少炎症细胞浸润,可减轻肾损伤。
Abstract:
Objective To investigate the effect of blocking pannexin-1 against acute kidney injury induced by cisplatin. Methods Twenty-six male C57BL/6 mice aged 6-8 weeks were randomly divided into control group, cisplatin model (Cis) group and cisplatin + carbenoxolone treatment group (Cis + CBX). In Cis group and Cis +CBX group, the mice were injected intraperitoneally with 20 mg/kg of cisplatin and with CBX (20 mg/kg) at 30 min before and 24 and 48 h after cisplatin inhjection, respectively. All the mice were sacrificed at 72 h after cisplatin injection, and plasma and kidney samples were collected for testing mRNA and protein expression levels of pannexin-1 in the renal tissue using RT-qPCR and Western blotting and for detecting plasma creatinine and BUN levels; the pathological changes in the renal tissues were observed using Periodic Acid-Schiff staining. The expression of kidney injury molecule 1 (KIM-1) was examined using immunohistochemistry and the mRNA expressions of KIM-1 and neutrophil gelatinase- related lipid transport protein (NGAL) were detected by RT-qPCR to evaluate the injuries of the renal tubules. The infiltration of F4/80-positive macrophages and CD4-positive T cells were observed by immunofluorescence. In the in vitro experiment, human proximal tubule epithelial cell line HK-2 was stimulated with 50 μmol/L cisplatin to establish a cell model of acute kidney injury, and the mRNA and protein expressions of pannexin-1 were detected by RT-qPCR and Western blotting at 4, 6, 12, 18 and 24 h after the stimulation. Results Compared with the control mice, the cisplatin-treated mice showed significantly up-regulated protein levels (P<0.05) and mRNA levels (P< 0.005) of pannexin-1 in the kidney tissue. Cisplatin stimulation also caused significant increases in the protein levels (P<0.005) and mRNA levels (P<0.005) of pannexin-1 in cultured HK-2 cells. Compared with cisplatin-treated mice, the mice treated with both cisplatin and the pannexin-1 inhibitor CBX showed obviously lessened kidney pathologies and milder renal tubular injuries with significantly reduced plasma BUN and Scr levels (P<0.01), expressions of KIM-1 and NGAL in the kidney (P< 0.05), and infiltration of F4/80-positive macrophages (P<0.01) and CD4- positive T cells (P<0.05) in the kidney tissues. Conclusion In cisplatin induced acute kidney injury mice model, Pannexin-1 expression is up-regulated in the kidneys tissue, and blocking pannexin-1 alleviates the acute kidney injury via reducing renal inflammatory cell infiltration.

相似文献/References:

[1]余乐,陈明辉,古春萍,等.顺铂下调铜离子转运蛋白1诱导人食管鳞癌细胞EC109耐药[J].南方医科大学学报,2011,(05):801.
[2]林晓丹,石兴源,周同冲,等.调强或三维适形放疗联合TP 方案化疗治疗局部中晚期食管癌的临床研究[J].南方医科大学学报,2011,(07):1264.
[3]陈斯泽,陈雪梅,丁颖,等.Combined chemotherapy with cisplatin, docetaxel and capecitabine for metastatic nasopharyngeal carcinoma:a retrospective analysis[J].南方医科大学学报,2011,(07):1114.
[4]彭萍,吴璇,关婷,等.1-磷酸-神经鞘氨醇干预化疗对荷瘤小鼠卵巢功能和抑瘤效果的影响[J].南方医科大学学报,2012,(03):383.
[5]杨义明,张水兰,宋华勇,等.TP方案治疗难治性晚期食管鳞癌的临床观察[J].南方医科大学学报,2004,(09):1042.
 YANG Yi-ming,ZHANG Shui-lan,SONG Hua-yong,et al.Clinical observation of TP regiment for treating refractory and terminal squamous cancer of the esophagus[J].Journal of Southern Medical University,2004,(05):1042.
[6]冯正富,潘辉林,宋慧胜,等.同期放化疗治疗中晚期鼻咽癌临床研究[J].南方医科大学学报,2004,(06):694.
 FENG Zheng-fu,PAN Hui-lin,SONG Hui-sheng,et al.Radiotherapy with concurrent chemotherapy for treatment of advanced nasopharyngeal carcinoma[J].Journal of Southern Medical University,2004,(05):694.
[7]曹漫明,张积仁,汪森明,等.卵巢癌顺铂耐药细胞中DNA转录与修复相关基因的表达[J].南方医科大学学报,2005,(12):1478.
 CAO Man-ming,ZHANG Ji-ren,WANG Sen-ming,et al.Expression of DNA transcription-and repair-related genes in cisplatin-resistant human ovarian carcinoma cell line COC1/DDP[J].Journal of Southern Medical University,2005,(05):1478.
[8]宋乐乐,马琳艳,张旭东,等.衣霉素联合顺铂对人鼻咽癌细胞增殖和凋亡的影响[J].南方医科大学学报,2012,(06):766.
[9]兰曦,王勇,曹姝,等.RNA干扰抑制CD133 表达对CD133+肝癌干细胞增殖和化疗敏感性的影响[J].南方医科大学学报,2012,(12):1741.
[10]浦龙健,黄莹莹,李阳,等.siRNA沉默葡萄糖调节蛋白78可增强乳腺癌细胞对顺铂的敏感性[J].南方医科大学学报,2013,(01):44.

更新日期/Last Update: 1900-01-01